Loading...
XNYS
WST
Market cap25bUSD
Jul 09, Last price  
357.66USD
1D
1.13%
1Q
39.41%
Jan 2017
321.62%
Name

West Pharmaceutical Services Inc

Chart & Performance

D1W1MN
XNYS:WST chart
P/E
51.18
P/S
8.22
EPS
6.99
Div Yield, %
0.24%
Shrs. gr., 5y
-0.83%
Rev. gr., 5y
7.44%
Revenues
3.07b
+6.26%
913,300,0001,020,100,0001,051,099,9991,055,700,0001,104,700,0001,192,600,0001,266,400,0001,368,200,0001,421,700,0001,398,000,0001,509,100,0001,600,200,0001,718,000,0001,843,600,0002,146,699,9992,830,700,0002,885,500,0002,951,100,0002,892,700,0003,073,700,000
Net income
494m
+0.20%
67,100,00070,700,00086,000,00072,600,00065,300,00075,500,00080,700,000112,300,000127,100,00095,600,000143,600,000150,700,000206,900,000241,700,000346,200,000661,800,000585,900,000593,400,000492,700,000493,700,000
CFO
755m
+15.52%
143,800,000129,200,000135,000,000137,700,000138,300,000130,700,000187,400,000220,500,000182,900,000212,400,000219,400,000263,300,000288,600,000367,200,000472,500,000584,000,000724,000,000776,500,000653,400,000754,800,000
Dividend
Apr 29, 20260.22 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
IPO date
Jul 27, 1923
Employees
10,700
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT